Method of treating chronic kidney disease
AssigneePanion & BF Biotech Inc.
InventorsKeith Chan, Winston Town
Life of this patent
Estimating the term…
Abstract
The present invention discloses pharmaceutical-grade ferric organic compounds having enhanced dissolution rate. These ferric organic compounds, including but are not limited to ferric citrate, are useful for treating chronic kidney disease.
Claims30
A method of treating a subject having chronic kidney disease, comprising administering to said subject an effective amount of a ferric organic compound having a dissolution rate of at least approximately 2 mg/cm2/min.
2-4. (canceled)
(canceled)
(canceled)
17-20. (canceled)
A method of treating a subject having chronic kidney disease, comprising administering to said subject an effective amount of a ferric organic compound.
22-23. (canceled)
(canceled)
27-28. (canceled)
A therapeutic regimen for a subject having chronic kidney, the regiment comprising a pharmaceutical composition comprising an acceptable carrier and an effective amount of ferric organic compound having a dissolution rate of at least 2 mg/cm2/min., wherein the pharmaceutical composition is administered in single or multiple doses regimens.
31-33. (canceled)
(canceled)
39-45. (canceled)
Dependencies are inferred from the claim text.